VIRBAMINTHE 25ML | Treatment for Ascaris Infestations

VIRBAMINTHE

2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substances:

For the full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Oral paste.
4. CLINICAL DATA
4.1. target species
Dogs and cats.
4.2. Indications of use
Dogs (from two weeks of age): Treatment for roundworm infestations,
toxocara canis y Toxascaris leonina; by hookworms, Ancylostoma caninum, hookworm
Brazilian y Hookworm stenocephala; and by cestodes, Canine dipylidium y Taenia spp.
Cats (from three weeks of age): Treatment for roundworm infestations,
toxocara cati y Toxascaris leonina; by hookworms, Ancylostoma tubaeforme, Ancylostoma
braziliense and Uncinaria stenocephala; and by cestodes, Canine dipylidium y Taenia spp.
4.3. contraindications
Do not administer the drug if the animal presents diarrhea and in case of occlusions
intestinal.
Do not administer to animals with known hypersensitivity to the active substances or excipients.
Do not use in case of suspected resistance to benzimidazoles.
4.4. Special warnings for each target species
They have not been described.
4.5. Special precautions for use and special precautions for the person who
administer the product to animals
Special precautions for use:
Are not necessary.
Special precautions for the person administering the product to animals:
People with known hypersensitivity to the active substances or excipients should
avoid all contact with the veterinary medicinal product.
Avoid contact with skin and mucous membranes.
In case of accidental spillage on the skin, wash with plenty of water.
It is advisable to wash your hands after handling the product.
4.6. Adverse effects (frequency and severity)
Its use at prescribed doses has no side effects; however, some animals
They may present a symptomatic picture with diarrhoea, nausea or vomiting, which ceases
spontaneously or upon discontinuation of treatment.
4.7. Use during pregnancy, lactation or lay
Contraindications have not been described during pregnancy or lactation.
4.8. Interaction with other medicinal products and other forms of interaction

They have not been described.
4.9. Dosage and method of administration
Orally.
Dose: 15 mg of oxibendazole and 120 mg of niclosamide/kg body weight, in a single dose, which
equals 0.5 ml/kg bw
Virbaminthe comes in three sizes of graduated injectors:
In the 5 ml injector each graduation corresponds to the treatment of 500 g of live weight.
In the 10 ml injector each graduation corresponds to the treatment of 2 kg of live weight.
In the 20 ml injector each graduation corresponds to the treatment of 10 kg of live weight.
Graduate the injector according to the weight of the animal and press the piston once the injection has been introduced.
cannula in the mouth.
It is advisable to administer the medication in the morning, in a single dose, directly on the
animal's tongue or mixed with food.
Deworming program:
– puppies of dogs and cats (over 2 and 3 weeks of age, respectively):
Deworm twice, one month apart, between the 6th and 12th week.
– bitches and cats, deworm three times:
– at the time of coverage.
– one week before delivery.
– 3-4 weeks after delivery.
– dogs and cats, deworm at least 3-4 times a year.
4.10. Overdose (symptoms, emergency measures, antidotes)
There is no information available.
4.11. Waiting time
Not applicable.
5. PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group: Antiparasitic, insecticide and repellent products: benzimidazoles and
related substances, oxibendazole and combinations.
ATCvet code: QP52AC57.

6. PHARMACEUTICAL DATA
6.1. List of excipients
Sodium metabisulfite, E-223.
Sodium benzoate, E-211.
dequalinium chloride.
Xanthan gum.
Sodium polynaphthalene sulfonate.
sodium cyclamate.
Anchovy powder.
Dimethicone.
Purified water.
6.2. Main incompatibilities
They have not been described.
6.3. Shelf-life of the medicinal product, if necessary after reconstitution of the
medication or when the immediate packaging is first opened.
Shelf life of the veterinary medicinal product packaged for sale: 18 months.
Shelf-life after first opening the immediate packaging: 6 months.
6.4. Special storage precautions
Keep the injector clean after each manipulation, in the original box.
This veterinary medicinal product does not require special storage conditions.
6.5. Nature and composition of the primary packaging
Multi-dose oral syringe made of high-density polyethylene plastic graduated in
divisions, with plunger of the same material. The plunger has a plug and a ring that allows
dosage graduation.
The syringe can be contained in a cardboard box, or also in a transparent blister pack.

6.6. Special precautions for disposal of the veterinary medicinal product
used or, where appropriate, the residues derived from its use
Any unused veterinary medicinal product or residues derived from it must be
disposed of in accordance with local regulations.

See technical sheet

VIRBAMINTHE